CaryHealth executives presented insights on the strategic implementation of artificial intelligence in pharmacy practice at Asembia's AXS25 Summit in Las Vegas, highlighting both the transformative potential and appropriate limitations of AI technology in healthcare.
Chief Technology Officer Matt Hawkins and CEO Areo Nazari outlined how AI can enhance patient care by freeing pharmacists to focus on direct patient interactions while streamlining operations through improved inventory management and automated patient communications.
Nazari demonstrated AI's clinical value by showing how large language models can quickly provide precise dosing regimens for complex cases, such as IV vancomycin dosing for patients with renal impairment, complete with safety considerations and clinical references.
However, the CaryHealth team emphasized that human expertise remains irreplaceable in pharmacy practice. They cautioned against using AI as a barrier between patients and pharmacists or for delivering sensitive medical information like lab results and complex diagnoses.
"AI should enable our pharmacists to be incredibly human," Nazari noted, underscoring CaryHealth's philosophy that technology should enhance rather than replace the essential human elements of pharmaceutical care.
Read the full article in Specialty Pharmacy Continuum →
